Éric DesRosiers
President chez Northern Therapeutics, Inc.
Profil
Éric DesRosiers is currently the Director at Le Devoir, Inc. and also holds the position of Director at Séminaire des Trois-Rivières and President at Northern Therapeutics, Inc. Previously, he worked as Development Director at KLOX Technologies, Inc., Vice President-Operations & New Technologies at BioSyntech, Inc., and Project Leader-Living Skin Replacement at Apotex Corp.
Dr. DesRosiers pursued his undergraduate degree at the University of Ottawa and completed his graduate and doctorate degrees at the University of Montréal.
Postes actifs de Éric DesRosiers
| Sociétés | Poste | Début |
|---|---|---|
Le Devoir, Inc.
 Le Devoir, Inc. Publishing: NewspapersConsumer Services Le Devoir, Inc. operates as an online newspaper. It publishes articles talk about history, politics, culture, society issues, economy, arts, sports, and sciences. The company was founded by Henri Bourassa on January 10, 1910 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | 13/12/2017 |
Séminaire des Trois-Rivières
 Séminaire des Trois-Rivières Other Consumer ServicesConsumer Services Séminaire des Trois-Rivières provides education services. It offers library, arts, sports and residence. The company is headquartered in Trois-Rivières, Canada. | Directeur/Membre du Conseil | - |
Northern Therapeutics, Inc.
 Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada. | President | - |
Anciens postes connus de Éric DesRosiers
| Sociétés | Poste | Fin |
|---|---|---|
| KLOX TECHNOLOGIES INC | Corporate Officer/Principal | - |
Apotex Corp.
 Apotex Corp. Pharmaceuticals: MajorHealth Technology Apotex Corp. is a generic pharmaceuticals company, which offers generics, innovative molecules, and biotechnology products. The company was founded in 1999 and is headquartered in Weston, FL. | Corporate Officer/Principal | - |
| BIOSYNTECH, INC. | Directeur des opérations | - |
Formation de Éric DesRosiers
| University of Ottawa | Undergraduate Degree |
| University of Montréal | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOSYNTECH, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Le Devoir, Inc.
Le Devoir, Inc. Publishing: NewspapersConsumer Services Le Devoir, Inc. operates as an online newspaper. It publishes articles talk about history, politics, culture, society issues, economy, arts, sports, and sciences. The company was founded by Henri Bourassa on January 10, 1910 and is headquartered in Montreal, Canada. | Consumer Services |
Apotex Corp.
Apotex Corp. Pharmaceuticals: MajorHealth Technology Apotex Corp. is a generic pharmaceuticals company, which offers generics, innovative molecules, and biotechnology products. The company was founded in 1999 and is headquartered in Weston, FL. | Health Technology |
KLOX Technologies, Inc.
 KLOX Technologies, Inc. Medical SpecialtiesHealth Technology KLOX Technologies, Inc. designs and develops therapeutic and cosmetic products. The firm offers fluorescence biomodulation technology. The company was founded by Francesco Bellini in 2007 and is headquartered in Laval, Canada. | Health Technology |
Séminaire des Trois-Rivières
Séminaire des Trois-Rivières Other Consumer ServicesConsumer Services Séminaire des Trois-Rivières provides education services. It offers library, arts, sports and residence. The company is headquartered in Trois-Rivières, Canada. | Consumer Services |
Northern Therapeutics, Inc.
Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
